Berg A - Search Results

1

Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts.

Jones A, Saini J, Kriel B, Via LE, Cai Y, Allies D, Hanna D, Hermann D, Loxton AG, Walzl G, Diacon AH, Romero K, Higashiyama R, Liu Y, Berg A. Jones A, et al. Among authors: berg a. BMC Infect Dis. 2022 Apr 2;22(1):327. doi: 10.1186/s12879-022-07308-3. BMC Infect Dis. 2022. PMID: 35366820 Free PMC article.

2

Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug development.

Polak S, Romero K, Berg A, Patel N, Jamei M, Hermann D, Hanna D. Polak S, et al. Among authors: berg a. J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):457-467. doi: 10.1007/s10928-018-9580-2. Epub 2018 Mar 8. J Pharmacokinet Pharmacodyn. 2018. PMID: 29520534 Free PMC article.

3

Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin.

Patel N, Hatley O, Berg A, Romero K, Wisniowska B, Hanna D, Hermann D, Polak S. Patel N, et al. Among authors: berg a. AAPS J. 2018 Mar 14;20(3):47. doi: 10.1208/s12248-018-0199-4. AAPS J. 2018. PMID: 29541956

4

Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics.

Srivastava S, Deshpande D, Magombedze G, van Zyl J, Cirrincione K, Martin K, Bendet P, Berg A, Hanna D, Romero K, Hermann D, Gumbo T. Srivastava S, et al. Among authors: berg a. J Antimicrob Chemother. 2020 Feb 1;75(2):392-399. doi: 10.1093/jac/dkz460. J Antimicrob Chemother. 2020. PMID: 31713607 Free PMC article.

5

Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis.

Mallikaarjun S, Chapagain ML, Sasaki T, Hariguchi N, Deshpande D, Srivastava S, Berg A, Hirota K, Inoue Y, Matsumoto M, Hafkin J, Geiter L, Wang X, Gumbo T, Liu Y. Mallikaarjun S, et al. Among authors: berg a. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01207-20. doi: 10.1128/AAC.01207-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33106263 Free PMC article.

6

Development of physiologically-based pharmacokinetic models for standard of care and newer tuberculosis drugs.

Humphries H, Almond L, Berg A, Gardner I, Hatley O, Pan X, Small B, Zhang M, Jamei M, Romero K. Humphries H, et al. Among authors: berg a. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1382-1395. doi: 10.1002/psp4.12707. Epub 2021 Oct 8. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34623770 Free PMC article. Review.

7

Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative Database.

Berg A, Clary J, Hanna D, Nuermberger E, Lenaerts A, Ammerman N, Ramey M, Hartley D, Hermann D. Berg A, et al. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0179321. doi: 10.1128/AAC.01793-21. Epub 2022 Jan 31. Antimicrob Agents Chemother. 2022. PMID: 35099274 Free PMC article.

8

Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.

Gumbo T, Srivastava S, Deshpande D, Pasipanodya JG, Berg A, Romero K, Hermann D, Hanna D. Gumbo T, et al. Among authors: berg a. J Antimicrob Chemother. 2023 Apr 3;78(4):953-964. doi: 10.1093/jac/dkad029. J Antimicrob Chemother. 2023. PMID: 36794692 Free PMC article.

9

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.

Conrado DJ, Larkindale J, Berg A, Hill M, Burton J, Abrams KR, Abresch RT, Bronson A, Chapman D, Crowther M, Duong T, Gordish-Dressman H, Harnisch L, Henricson E, Kim S, McDonald CM, Schmidt S, Vong C, Wang X, Wong BL, Yong F, Romero K; Duchenne Muscular Dystrophy Regulatory Science Consortium (D-RSC). Conrado DJ, et al. Among authors: berg a. J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):441-455. doi: 10.1007/s10928-019-09642-7. Epub 2019 May 24. J Pharmacokinet Pharmacodyn. 2019. PMID: 31127458

10

Association between arterial stiffness, carbamylation, and mortality in patients undergoing coronary angiography with no or mild chronic kidney disease.

Daschner C, Kleber ME, Stach K, Yuecel G, Husain-Syed F, Ayasse N, Berg AH, März W, Krämer BK, Yazdani B. Daschner C, et al. Among authors: berg ah. Cardiorenal Med. 2024 Dec 19:1-21. doi: 10.1159/000543143. Online ahead of print. Cardiorenal Med. 2024. PMID: 39701045 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,429 results

Search Page

Filters